Anna Calarco Selected Research

Anna Calarco Research Topics

Disease

6	Neoplasms (Cancer) 02/2023 - 06/2013
3	Inflammation (Inflammations) 04/2023 - 02/2023
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2023 - 10/2020
2	Necrosis 03/2023 - 02/2017
2	Wounds and Injuries (Trauma) 03/2023 - 11/2021
2	Neoplasm Metastasis (Metastasis) 02/2023 - 01/2020
2	Osteoarthritis 02/2023 - 06/2022
2	Infections 08/2021 - 06/2020
1	Acantholysis 07/2023
1	Pemphigus (Pemphigus Vulgaris) 07/2023
1	Autoimmune Diseases (Autoimmune Disease) 07/2023
1	Blister (Bulla) 07/2023
1	Dry Eye Syndromes (Dry Eye Syndrome) 04/2023
1	Wound Infection (Wound Infections) 03/2023
1	Atopic Dermatitis (Atopic Eczema) 01/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Epilepsy (Aura) 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Periodontal Pocket (Periodontal Pockets) 03/2022
1	Periodontal Diseases (Periodontal Disease) 03/2022
1	Smear Layer 11/2021
1	Leishmaniasis 01/2021
1	Nervous System Diseases (Neurological Disorders) 11/2020
1	Huntington Disease (Huntington's Disease) 10/2020
1	Persistent Infection 06/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Retinoblastoma (Glioblastoma, Retinal) 02/2017
1	Sarcoma (Soft Tissue Sarcoma) 02/2017
1	Leukemia 10/2015
1	Hematologic Neoplasms (Hematological Malignancy) 10/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2015

Drug/Important Bio-Agent (IBA)

3	ResveratrolIBA 04/2023 - 06/2020
2	MicroRNAs (MicroRNA)IBA 07/2023 - 01/2020
2	HydrogelsIBA 04/2023 - 01/2023
2	QuercetinIBA 03/2023 - 01/2023
2	poly(lactide) (polylactic acid)IBA 03/2023 - 03/2022
2	ChitosanIBA 01/2023 - 06/2022
2	SolutionsIBA 08/2021 - 06/2020
2	Carnitine (L-Carnitine)FDA LinkGeneric 10/2020 - 10/2015
1	Immunoglobulin G (IgG)IBA 07/2023
1	Desmoglein 3IBA 07/2023
1	AntibodiesIBA 07/2023
1	AutoantibodiesIBA 07/2023
1	Sirtuin 1IBA 04/2023
1	Ophthalmic Solutions (Eye Drops)IBA 04/2023
1	Tumor Biomarkers (Tumor Markers)IBA 03/2023
1	methylallyl trisulfide (MATS)IBA 03/2023
1	AntioxidantsIBA 03/2023
1	EndopeptidasesIBA 02/2023
1	Small Interfering RNA (siRNA)IBA 02/2023
1	Matrix Metalloproteinases (MMPs)IBA 02/2023
1	ZincIBA 02/2023
1	Hyaluronic Acid (Hyaluronan)IBA 01/2023
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023
1	caffeic acidIBA 01/2023
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2023
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2023
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2023
1	N-Methylaspartate (NMDA)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 06/2022
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 06/2022
1	2,3-dialdehydocelluloseIBA 11/2021
1	GelatinIBA 11/2021
1	Composite ResinsIBA 11/2021
1	CurcuminIBA 08/2021
1	2- (((5- methyl- 2- thienyl)methylene)amino)- N- phenylbenzamideIBA 01/2021
1	Leishmaniasis VaccinesIBA 01/2021
1	human SLC22A5 proteinIBA 10/2020
1	3-(2,2,2-trimethylhydrazine)propionateIBA 10/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2020
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 01/2020
1	LipidsIBA 01/2020
1	AndrogensIBA 01/2020
1	PolymersIBA 01/2020
1	GoldIBA 10/2018
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2015
1	TransferasesIBA 10/2015
1	ST1326IBA 10/2015
1	CarbonIBA 10/2015
1	polycaprolactoneIBA 06/2013
1	Biocompatible Materials (Biomaterials)IBA 06/2013
1	titanoceneIBA 06/2013

Therapy/Procedure

3	Therapeutics 06/2022 - 01/2020
1	Aftercare (After-Treatment) 07/2023
1	Surgical Amputation (Amputations) 03/2023
1	Palliative Care (Palliative Therapy) 06/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Traditional Medicine (Folk Remedies) 11/2020
1	Radiotherapy 02/2017